Kynam Capital Management, LP BCRX Holdings History
Kynam Capital Management, LP's BioCryst Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Kynam Capital Management, LP held 8.93 Mil shares of BioCryst Pharmaceuticals Inc(BCRX), totaling $66.96 Mil. This investment constitutes 5.63% of their stock portfolio, and Kynam Capital Management, LP now holds 4.27% of the outstanding BioCryst Pharmaceuticals Inc(BCRX) stock.
The initial trade took place in 2022Q2. And since then Kynam Capital Management, LP has made 8 purchases of BCRX, at an average price of $7.01, for a total of 10.02 Mil shares. In addition, there have been 3 sales at an average price of $12.02 for 1.09 Mil shares. Based on historical transaction data and BCRX's current price of $9.35, Kynam Capital Management, LP's estimated gain on his BCRX holdings is $26.38 Mil, reflecting a 37.56% gain to date.
Kynam Capital Management, LP BCRX ($9.35) Holding Chart
Kynam Capital Management, LP BCRX ($9.35) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
